134 related articles for article (PubMed ID: 10670248)
1. Short term treatment with prostanoids in critical limb ischaemia: three months follow-up.
Martini R; Camporese G; Salmistraro G; Scomparin MA; Verlato F; Andreozzi GM
Minerva Cardioangiol; 1999 Dec; 47(12):656-7. PubMed ID: 10670248
[No Abstract] [Full Text] [Related]
2. Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1. The ICAI Study Group. Ischemia Cronica degli Arti Inferiori.
Ann Intern Med; 1999 Mar; 130(5):412-21. PubMed ID: 10068415
[TBL] [Abstract][Full Text] [Related]
3. PGE(1) short term therapy in critical lower limb ischemia.
Bandiera G; Forletta M; Di Paola FM; Cirielli C
Int Angiol; 2003 Mar; 22(1):58-63. PubMed ID: 12771858
[TBL] [Abstract][Full Text] [Related]
4. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
[TBL] [Abstract][Full Text] [Related]
5. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of prostanoids in patients with critical leg ischemia].
Brodszky V; Farkas K; Járai Z; Landi A; Pécsvárady Z; Baji P; Balogh O; Gulácsi L; Péntek M
Orv Hetil; 2011 Dec; 152(51):2047-55. PubMed ID: 22130202
[TBL] [Abstract][Full Text] [Related]
7. Prostanoids for critical limb ischaemia.
Ruffolo AJ; Romano M; Ciapponi A
Cochrane Database Syst Rev; 2010 Jan; (1):CD006544. PubMed ID: 20091595
[TBL] [Abstract][Full Text] [Related]
8. [Administration of the generic prostaglandin E1 VAP 20® in patients with lower limb critical ischaemia: a prospective study].
Pokrovskiĭ AV; Chupin AV; Parshin PIu; Mikhaĭlov IP; Lavrenov VN; Kharazov AF; Kutyrev OE
Angiol Sosud Khir; 2013; 19(2):17-20, 22-4. PubMed ID: 23863787
[TBL] [Abstract][Full Text] [Related]
9. Study of thrombinic activation indexes, in patients with lower limb critic ischaemia, before and after prostaglandin E1 therapy.
Trifiletti A; Bartolone S; Scamardi R; Pizzoleo MA; Attinà A; Sottilotta G; Canobbio V; Soraci S; Barbera N
Minerva Cardioangiol; 1999 Mar; 47(3):55-8. PubMed ID: 10389444
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
Commeau P; Barragan P; Roquebert PO
Catheter Cardiovasc Interv; 2006 Nov; 68(5):793-8. PubMed ID: 17039538
[TBL] [Abstract][Full Text] [Related]
11. [Short- and long-term evaluation of treatment of critical ischemia of the lower lim with PGE1 (alprostadyl alpha-cyclodestrine)].
Amitrano M; Izzo M; Castaldo G; Lombardi R; Tizzano R; Bellizzi AM; Vietri GC; Sorrentino A; D'Avanzo A
Minerva Cardioangiol; 1996; 44(7-8):391-6. PubMed ID: 8965998
[TBL] [Abstract][Full Text] [Related]
12. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
[No Abstract] [Full Text] [Related]
13. [Global analysis of data from studies with PDE1 alpha-cyslodextrin].
Laurora G; Belcaro G; Cesarone MR; Incandela L; De Sanctis MT; Dugall M
Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):65-8. PubMed ID: 10658448
[TBL] [Abstract][Full Text] [Related]
14. ["Responders and non-responders" to PGE1 and alpha-cyclodextrin].
De Sanctis MT; Incandela L; Iacobitti P
Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):31-6. PubMed ID: 10658442
[TBL] [Abstract][Full Text] [Related]
15. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
Heidrich H
Hamostaseologie; 2006 Aug; 26(3):220-3. PubMed ID: 16906239
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life after revascularization for peripheral arterial occlusive disease: long-term follow-up.
Wann-Hansson C; Hallberg IR; Risberg B; Lundell A; Klevsgard R
J Adv Nurs; 2005 Aug; 51(3):227-35. PubMed ID: 16033590
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with prostanoid drugs. Analysis of 131 cases].
Castagno PL; Di Molfetta L; Merlo M; Barile G; Gaia S; Buzzacchino A; Ponzio F
Minerva Cardioangiol; 1999 Dec; 47(12):658-9. PubMed ID: 10670249
[No Abstract] [Full Text] [Related]
18. [Economic assessment of efficacy of vasaprostan treatment of critical lower limbs ischemia].
Vorob'ev PA; Dergach EV; Gerasimov VB; Avksent'eva MV
Ter Arkh; 2001; 73(8):59-63. PubMed ID: 11599270
[TBL] [Abstract][Full Text] [Related]
19. [Alprostan for management of critical lower limb ischemia].
Pokrovskiĭ AV; Dan VN; Chupin AV; Kalinin AA
Angiol Sosud Khir; 2005; 11(1):7-10. PubMed ID: 16034317
[TBL] [Abstract][Full Text] [Related]
20. Effects of alprostadil on blood rheology and nucleoside metabolism in patients affected with lower limb chronic ischaemia.
Acciavatti A; Laghi Pasini F; Capecchi PL; Messa GL; Lazzerini PE; De Giorgi L; Acampa M; Di Perri T
Clin Hemorheol Microcirc; 2001; 24(1):49-57. PubMed ID: 11345234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
